banner product

TESTS
 

 

A Rapid and Precise Diagnostic Test for the Detection of the Hemoplasma in Cats

 

 

Feline haemotropic mycoplasmosis is a worldwide important disease which may be fatal. It was previously called feline haemobartonellosis and frequently confused with another disease group feline bartonellosis. Feline bartonellosis, which differs largely from haemotropic mycoplasmosis, is seldom associated with clinical disease in most cases.

 

The three species that most commonly infect cats are 'Mycoplasma haemofelis', ‘Candidatus Mycoplasma haemominutum’, and  ‘Candidatus M. turicensis’. Among them, Candidatus M. haemominutum’ is the most common species revealed in prevalence studies, but the most pathogenic is Mycoplasma haemofelis. Coinfection can occur and ‘Candidatus M. turicensis’ seldom infect cats alone.

While a significant number of infected cats are asymptomatic carriers, the infection may cause severe hemolytic anemia and death in cats with acute infection, especially in young cats infected with M. haemofelis. 

 

While some cats will show no symptoms of infection, others may show minor symptoms of anemia, and still others may lose all of their energy and die:

  • Sudden onset of fever
  • Depression
  • Weakness
  • Lack of appetite
  • Whitish to pale purple gums

 

 

 

THE QubeMDx SOLUTION

Using a proprietary Polymerase Chain Reaction (PCR) technology, the QubeMDx performs the detection of FELINE HEMOPLASMA in only 15 minutes.

 

The QubeMDx is a real Point-of-Care solution that empowers the veterinarian with the right information, at the right time, so they can make the right decision and provide the best course of treatment for the animal.

  • Instant Detection of Mycoplasma haemofelis (MhF) and Candidatus Mycoplasma Haemominutum (CMhm).
  • High Accuracy and Specificity.
  • Shorter Turnaround Time.
  • Faster Medical Decision.

solution advantages

 

DIAGNOSTIC PROCEDURE

 

CONTACT

We at Credo pioneer accessible diagnostic platforms to improve the lives of those we love. We believe providing the right information to the right people at the right time leads to better outcomes.